Respira Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Respira Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study (NCT04266197) | Respira Therapeutics, Inc. | 2020-09-25 |
| A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension (NCT05343637) | Respira Therapeutics, Inc. | 2019-07-30 |
| A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234 (NCT05567367) | Respira Therapeutics, Inc. | 2018-07-31 |
Track Respira Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.